Eu Ppe Regulation Consultant

Scope and evidence must be confirmed before any paid tests or filings.

An EU PPE Regulation consultant should settle the regulatory route before a manufacturer buys tests or books a notified body. Regulation (EU) 2016/425 governs PPE placed on the EU market; the advisory output is a reasoned scope and risk-category position, a gap register and an evidence plan—not a promise that CE marking will be granted.

First decide whether the protective claim puts the product inside the PPE Regulation

Start with the product's intended protective function, exact claims on packaging and sales pages, foreseeable uses, user groups, and the complete system of interchangeable protective components or non-permanently fixed connection systems. PPE can include equipment worn or held against health or safety risks, essential interchangeable components and certain connection systems (Article 3). A name such as “work glove” does not settle the legal category.

Check Article 2 exclusions before classification: for example, some military/law-enforcement equipment, certain private-use protection against ordinary weather or dishwashing water, and covered motorcycle helmets. A product may raise additional legal regimes, such as medical-device rules, depending on its intended purpose; do not assume a PPE assessment by itself resolves every applicable act.

Risk category drives the legal conformity route

Record each claimed hazard and its plausible severity. Apply Annex I to the risks addressed by the equipment, then Article 19 to the resulting category. The following matrix is a routing test, not an automatic classification of whole product families.

Risk position	Applicable procedure	Strategy gate before spend
I. Only the limited minimal risks specified in Annex I (e.g. superficial mechanical injury or ordinary sunlight exposure)	Module A: internal production control; no notified-body EU type-examination required for this route	Show why every stated protective claim stays within the exhaustive Category I list.
II. Risks outside Categories I and III	Module B EU type-examination by a notified body, then Module C internal production control	Fix the representative design and claims before choosing a body with the appropriate notified scope.
III. Annex I serious-consequence risks, e.g. harmful biological agents, falls from height, harmful noise or drowning	Module B plus either Module C2 supervised product checks or Module D production-process quality assurance	Compare ongoing C2/D obligations and production model before committing; check Article 19's narrow single-unit, individually fitted derogation.

The single-unit derogation in Article 19 is narrow: for Category III PPE produced as one unit to fit an individual user, the Category II procedure (B + C) may be followed. It is not an exemption from Annex II requirements or conformity assessment, and it must not be extended to ordinary customisable series production.

Do not choose Category I just because an item looks simple; conversely, not every glove or helmet is automatically Category III. If an item makes multiple protective claims, document how each hazard changes the classification. A notified body is a legally designated independent assessor—not a consultant that can approve its own design advice.

Separate legal duties from the chosen technical evidence

Annex II contains mandatory essential health and safety requirements; Annex III defines minimum technical-documentation content. A standard is not the Regulation. A harmonised standard whose reference is published in the Official Journal gives a presumption of conformity only for the requirements and parts it actually covers (Article 14). Other technical specifications may be used if a defensible compliance demonstration is made.

Check the precise standard edition, scope, restrictions and withdrawal dates against the Official Journal rather than relying on a supplier's “EN tested” label. Commission Implementing Decision (EU) 2026/1279 replaced 2023/941; Decision (EU) 2026/1971 amended it in September 2026. The Commission's consolidated standard list is useful for screening but says it has no independent legal effect.

Transition matters: although Decision (EU) 2026/1279 repealed Decision (EU) 2023/941, Article 2 preserves the application of specified older references until their withdrawal dates in Annex II. For a legacy report, check the exact reference and its withdrawal date; do not assume the latest edition immediately invalidates every earlier report.

Evidence-reuse matrix: what can travel from an earlier product?

Before commissioning repeat tests, reconcile every old document with the marketed variant. “Usable” below means a candidate for technical assessment, never an automatic legal transfer of an EU type-examination certificate.

Existing item	Reuse condition to verify	Gap / safe next move
Test report on a predecessor	Same risk, configuration, material, method, standard edition and sample traceability?	Build a differences matrix; ask the appropriate assessor whether supplementary evidence or retesting is needed.
Supplier material or component results	Can the traceable data substantiate a requirement of the finished assembled PPE?	Map it to Annex II; do not treat a component report as complete-product conformity.
EU type-examination certificate	Does the named manufacturer, type and permitted variation scope match; is it valid and issued by a notified body within scope?	Review annexes, changes and notified scope; obtain the body's position before claiming certificate coverage.
Earlier declaration, labels and instructions	Do risk claims, applicable acts, language(s) and responsible economic operator still match?	Update the technical dossier and EU declaration; verify each target Member State's instruction/language requirements.

An EU type-examination certificate is not indefinite: Annex V, point 6.1 limits the validity of a newly issued or renewed certificate to no more than five years. Check its actual expiry date, approved type, conditions and any notified-body decision on changes or renewal before claiming coverage.

A third-party “voluntary CE certificate” is not a substitute for the assessment required by Article 19. Check the body's current PPE designation and product scope in NANDO; the European Commission expressly warns about misleading unregulated certificates.

A pre-testing decision file, not a substitute for certification

Identify who is the manufacturer under Article 3: placing own-branded PPE on the market or making a compliance-relevant modification can move manufacturer obligations to an importer or distributor (Article 12). An importer must verify the manufacturer's procedure, documents and markings before placement (Article 10). A non-EU manufacturer can mandate an EU authorised representative for specified tasks, but cannot delegate its design/compliance duties under Article 8(1) or drafting the technical file under Article 8(2) through that mandate.

Separately, Article 4 of Regulation (EU) 2019/1020 requires an economic operator established in the EU to carry out specified compliance tasks for PPE. This can be an EU manufacturer, importer, appropriately mandated authorised representative, or—if none of those exists—an eligible EU fulfilment service provider. Identify that operator, its tasks and contact details before market placement; this does not remove the manufacturer's own PPE obligations. Under Article 4(4), its identity and postal contact details must appear on the product, packaging, parcel or accompanying document. An online offer targeted at EU end users counts as making the product available on the market under Article 6.

The consultant's decision memorandum should name the protective-claim boundary, product variants, Annex I category reasoning, selected conformity modules, Annex II requirement-to-evidence map, harmonised-standard status, responsible operator, critical gaps, and go/no-go conditions. After conformity is demonstrated, the manufacturer draws up the EU declaration and affixes CE marking; For the ordinary Category III B+C2 or B+D route, Article 17(3) requires the number of the notified body involved in Annex VII or VIII production control. For the exceptional individually fitted single-unit B+C route, review the marking consequence separately rather than inventing a C2/D production-control body. Manufacturers retain technical documentation and the declaration for 10 years after market placement (Article 8(3)).

Suggested decision gates before execution:

Freeze packaging/marketing protection claims and identify all marketed variants and foreseeable uses.
Confirm scope, Annex I classification and any parallel regimes; put unresolved claims on hold.
Audit standards, existing test data, technical documentation and the notified body's authorised scope.
Approve a written route, evidence budget and change-control owner; only then procure detailed testing or certification execution.

For the subsequent operational stages, use PPE testing and evidence planning and PPE conformity-assessment execution. For consumer products where a separate general-product-safety question remains, review the GPSR scope analysis; overlapping regimes must be assessed on their own terms.

Questions that change the advice

Can a supplier's CE certificate make our imported PPE ready to sell?

Not by itself. Confirm the actual manufacturer, exact type and claims, applicable Article 19 modules, notified-body status where needed, importer checks and the accompanying declaration and instructions. A voluntary certificate is not the EU type-examination required for Category II or III.

Can we classify a glove as Category I because it protects from scratches?

Only if all claimed risks fit Annex I's limited Category I list. Added claims for hazardous chemicals or harmful biological agents can change the route materially; examine actual performance claims and foreseeable uses.

May one Category III model use Module C2 while another uses Module D?

Article 19 allows C2 or D following Module B. The choice must be made for the relevant approved product and production-control arrangements; compare sampling and quality-assurance implications before selecting the approach.

Is a harmonised EN standard mandatory and sufficient?

The binding requirements are in Annex II. Correctly cited harmonised standards can provide a limited presumption for requirements covered; non-harmonised evidence requires its own substantiation, and even full standard testing does not replace the applicable module or documentation.

Does redesign automatically invalidate all prior test reports?

Not automatically. Map changed materials, geometry, suppliers, claims, production and standard editions to affected hazards and evidence; ask the notified body where certificate scope or changes require its review.